We are live on ! Find out more
GCM

Galibier Capital Management Portfolio holdings

AUM $300M
1-Year Est. Return 22.03%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
AUM
$315M
AUM Growth
+$63.6M
Cap. Flow
+$44M
Cap. Flow %
13.96%
Top 10 Hldgs %
79.65%
Holding
36
New
5
Increased
7
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
RCI icon
Rogers Communications
RCI
+$31.6M
2
AZN icon
AstraZeneca
AZN
+$14.2M
3
GIL icon
Gildan
GIL
+$13.4M
4
PHG icon
Philips
PHG
+$7.26M
5
CVE icon
Cenovus Energy
CVE
+$5.57M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$14.5M
2
OSK icon
Oshkosh
OSK
+$4.75M
3
SRCL
Stericycle Inc
SRCL
+$4M
4
EMR icon
Emerson Electric
EMR
+$3.53M
5
RYAAY icon
Ryanair
RYAAY
+$2.29M

Sector Composition

Rank Sector Weight
1 Financials 29.21%
2 Energy 16.31%
3 Healthcare 13.72%
4 Communication Services 10.75%
5 Materials 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFC icon
1
Manulife Financial
MFC
$72.6B
$37.8M 11.99%
1,858,564
+112,748
+6% +$2.15M
CM icon
2
Canadian Imperial Bank of Commerce
CM
$107B
$37.3M 11.85%
895,640
+97,922
+12% +$4.14M
RCI icon
3
Rogers Communications
RCI
$17.7B
$32.6M 10.34%
+655,221
New +$31.6M
NTR icon
4
Nutrien
NTR
$32.7B
$32.1M 10.19%
669,119
+61,918
+10% +$2.99M
CVE icon
5
Cenovus Energy
CVE
$54.6B
$30.6M 9.71%
3,003,244
+613,847
+26% +$5.57M
ENB icon
6
Enbridge
ENB
$124B
$20.8M 6.6%
522,140
-25,326
-5% -$946K
AZN icon
7
AstraZeneca
AZN
$263B
$17.8M 5.66%
178,885
+150,305
+526% +$14.2M
GIB icon
8
CGI
GIB
$13.9B
$14.2M 4.51%
169,632
-8,054
-5% -$648K
EMR icon
9
Emerson Electric
EMR
$82.9B
$14.2M 4.5%
185,877
-48,995
-21% -$3.53M
GIL icon
10
Gildan
GIL
$9.25B
$13.5M 4.29%
+456,757
New +$13.4M
BNS icon
11
Scotiabank
BNS
$106B
$12M 3.81%
212,036
+14,955
+8% +$850K
PHG icon
12
Philips
PHG
$25.4B
$9.74M 3.09%
251,105
+200,623
+397% +$7.26M
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
$9.15M 2.91%
155,216
-37,496
-19% -$2.16M
FLR icon
14
Fluor
FLR
$7.29B
$4.28M 1.36%
+226,871
New +$4.12M
HSIC icon
15
Henry Schein
HSIC
$9.74B
$3.46M 1.1%
51,901
-2,655
-5% -$176K
STN icon
16
Stantec
STN
$7.69B
$3.26M 1.03%
115,108
-29,000
-20% -$717K
PCOM
17
DELISTED
Points.com Inc. Common Shares
PCOM
$2.34M 0.74%
153,254
MIDD icon
18
Middleby
MIDD
$6.05B
$1.98M 0.63%
18,099
-9,415
-34% -$1.08M
OSK icon
19
Oshkosh
OSK
$9.67B
$1.92M 0.61%
20,316
-55,144
-73% -$4.75M
BKNG icon
20
Booking.com
BKNG
$138B
$1.82M 0.58%
22,125
-5,675
-20% -$446K
ING icon
21
ING
ING
$93.8B
$1.52M 0.48%
125,893
-69,334
-36% -$794K
ABBV icon
22
AbbVie
ABBV
$458B
$1.43M 0.45%
16,103
-174,079
-92% -$14.5M
BUD icon
23
AB InBev
BUD
$158B
$1.42M 0.45%
17,258
-1,625
-9% -$135K
JPM icon
24
JPMorgan Chase
JPM
$939B
$1.22M 0.39%
8,731
-10,218
-54% -$1.31M
VOYA icon
25
Voya Financial
VOYA
$8.94B
$1.21M 0.38%
19,798
-12,335
-38% -$696K

Similar funds

Galibier Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Galibier Capital Management held 36 positions worth $315M, up 25% from $251M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Galibier Capital Management deployed $44M of net new capital in Q4 2019, opening 5 new positions and adding to 7 existing holdings. Its largest new stake was Rogers Communications: 655,221 shares worth $32.6M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 33% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $14.5M trimmed.

  • Galibier Capital Management's largest Q4 2019 buy was Rogers Communications: 655,221 shares worth $32.6M.
  • Galibier Capital Management added most to AstraZeneca in Q4 2019, an estimated $14.2M increase.
  • Galibier Capital Management's biggest Q4 2019 reduction was AbbVie, cutting an estimated $14.5M.
  • Galibier Capital Management fully exited Stericycle Inc in Q4 2019, selling an estimated $4M.
  • Galibier Capital Management's ten largest holdings make up 80% of its $315M portfolio in Q4 2019.
  • Galibier Capital Management opened 5 new positions and closed 1 in Q4 2019.
  • Galibier Capital Management's portfolio value rose 25% quarter-over-quarter to $315M.

Based on Galibier Capital Management's 13F filing for Q4 2019, filed 14 Jan 2020.